Virtual Medicinal Product (VMP)
-
Mesalazine 250mg suppositories
Name Details
Current Name
Mesalazine 250mg suppositories
|
Start Date
29-11-2002
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- suppository
- Unit Dose UOM
- suppository
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Rectal
- Form
- Suppository
- Ontology Form/Route
- suppository.rectal
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A07EC02
BNF |
Current BNF
01050100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
01050100
|
Start Date
06-03-2009
|
End Date
03-04-2022
|
Previous BNF
01050000
|
Start Date
02-02-2005
|
End Date
05-03-2009
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42296111000001108 |
29-09-2023 |
|
317401002 |
29-11-2002 |
28-09-2023 |
VMP Ingredients
VMP ingredients table
Mesalazine |
Based on Ingredient Substance |
|
250 mg |
|
Name
Mesalazine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
250
Strength and UOM (Dmr)
Parent Products
-
VTM
Mesalazine
-
VMP
(Current) Mesalazine 250mg suppositories
Virtual Medicinal Product Pack (VMPP) Information